iSpecimen Inc. 8-K

What Happened

• On May 13, 2026 (8-K filed), iSpecimen Inc. (Nasdaq: ISPC) announced it entered a Securities Purchase Agreement with accredited investors and closed the offering on May 11, 2026, raising approximately $2.5 million in gross proceeds. The Company issued 85,202 shares of common stock and 403,088 pre‑funded warrants (in lieu of shares that would have pushed certain buyers over a 4.99% beneficial ownership threshold). The per‑share price was $5.12; each pre‑funded warrant was sold for $5.1199 and is immediately exercisable for one share at $0.0001 per share. The Company will file a registration statement for resale of these securities within 30 days and used E.F. Hutton & Co. as placement agent.

Key Details

• Total securities authorized under the agreement: 488,281 shares (combination of common shares and pre‑funded warrants); closing issued 85,202 shares + 403,088 pre‑funded warrants.
• Gross proceeds at closing: ≈ $2.5 million (before placement agent fees and expenses); intended uses include working capital and up to $900,000 for marketing.
• Transfer and resale: securities sold in reliance on Section 4(a)(2) and Rule 506(b) (accredited investors); Company agreed to file an initial resale registration within 30 days after closing.
• Nasdaq listing: on May 12, 2026 Nasdaq notified the Company it regained compliance with the $1.00 minimum bid price rule (closing bids ≥ $1.00 for the 10 business days Apr 28–May 11, 2026).
• Annual meeting: the 2025 Annual Meeting has been repeatedly adjourned for lack of a quorum and is scheduled to reconvene May 29, 2026 at 9:00 AM ET.

Why It Matters

• The company raised fresh capital, which can help fund operations and marketing (up to $900k) without a public offering, but the issuance of pre‑funded warrants creates potential dilution if exercised (though exercisable at $0.0001 and subject to a 19.99% cap on investor ownership until stockholder approval under Nasdaq rules). Regaining Nasdaq compliance removes immediate delisting risk tied to the minimum bid price. Retail investors should note the funding reduces near‑term liquidity pressure, but watch for future stockholder votes, the registration filing for resale of the issued securities, and any dilution if the pre‑funded warrants are exercised.